These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29288743)

  • 1. The good and bad faces of the CXCR4 chemokine receptor.
    Teixidó J; Martínez-Moreno M; Díaz-Martínez M; Sevilla-Movilla S
    Int J Biochem Cell Biol; 2018 Feb; 95():121-131. PubMed ID: 29288743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion.
    Kucia M; Jankowski K; Reca R; Wysoczynski M; Bandura L; Allendorf DJ; Zhang J; Ratajczak J; Ratajczak MZ
    J Mol Histol; 2004 Mar; 35(3):233-45. PubMed ID: 15339043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
    Zhou W; Guo S; Liu M; Burow ME; Wang G
    Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.
    Wang Z; Sun J; Feng Y; Tian X; Wang B; Zhou Y
    Tumour Biol; 2016 Jul; 37(7):8515-28. PubMed ID: 27079871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
    Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12 (SDF-1)/CXCR4 pathway in cancer.
    Teicher BA; Fricker SP
    Clin Cancer Res; 2010 Jun; 16(11):2927-31. PubMed ID: 20484021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M; Reca R; Miekus K; Wanzeck J; Wojakowski W; Janowska-Wieczorek A; Ratajczak J; Ratajczak MZ
    Stem Cells; 2005 Aug; 23(7):879-94. PubMed ID: 15888687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
    Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
    Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.
    Patrussi L; Baldari CT
    Curr Med Chem; 2011; 18(4):497-512. PubMed ID: 21143114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4 in breast cancer: oncogenic role and therapeutic targeting.
    Xu C; Zhao H; Chen H; Yao Q
    Drug Des Devel Ther; 2015; 9():4953-64. PubMed ID: 26356032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.
    Wescott MP; Kufareva I; Paes C; Goodman JR; Thaker Y; Puffer BA; Berdougo E; Rucker JB; Handel TM; Doranz BJ
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9928-33. PubMed ID: 27543332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4.
    Nagasawa T
    J Mol Med (Berl); 2014 May; 92(5):433-9. PubMed ID: 24722947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches.
    Xu L; Li Y; Sun H; Li D; Hou T
    Mol Biosyst; 2013 Aug; 9(8):2107-17. PubMed ID: 23702796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
    Scala S
    Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
    Floranović MP; Veličković LJ
    Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in the WHIM syndrome and the idiopathic CD4(+) T-cell lymphocytopenia].
    Biajoux V; Bignon A; Bouchet-Delbos L; Emilie D; Balabanian K
    Biol Aujourdhui; 2010; 204(4):273-84. PubMed ID: 21215244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.